ENANTA PHARMACEUTICALS INC — 10-Q Filings
39 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by ENANTA PHARMACEUTICALS INC (ENTA), sorted by most recent first. Each row links to the full filing on EdgarLookup. ENANTA PHARMACEUTICALS INC has filed 39 10-Q documents with the SEC since 2002. To view all SEC filings by ENANTA PHARMACEUTICALS INC, see the full filings list.
All
10-K
10-K/A
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFR14A
EFFECT
NT 10-Q
POSASR
REGDEX
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001193125-26-046502 | Feb 11, 2026 | Dec 31, 2025 |
| 10-Q | 10-Q | 0001193125-25-179795 | Aug 13, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-071340 | May 14, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0000950170-25-018810 | Feb 12, 2025 | Dec 31, 2024 |
| 10-Q | 10-Q | 0000950170-24-092714 | Aug 7, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-055581 | May 8, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0000950170-24-012796 | Feb 8, 2024 | Dec 31, 2023 |
| 10-Q | 10-Q | 0000950170-23-039754 | Aug 8, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-019842 | May 9, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0000950170-23-002134 | Feb 8, 2023 | Dec 31, 2022 |
| 10-Q | 10-Q | 0000950170-22-015515 | Aug 8, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-008483 | May 9, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0000950170-22-001018 | Feb 10, 2022 | Dec 31, 2021 |
| 10-Q | Q3 2021 10-Q | 0001564590-21-042612 | Aug 9, 2021 | Jun 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-026025 | May 10, 2021 | Mar 31, 2021 |
| 10-Q | 10-Q | 0001564590-21-004983 | Feb 9, 2021 | Dec 31, 2020 |
| 10-Q | 10-Q | 0001564590-20-038908 | Aug 10, 2020 | Jun 30, 2020 |
| 10-Q | 10-Q | 0001564590-20-024177 | May 11, 2020 | Mar 31, 2020 |
| 10-Q | ENTA_Q1_FY20 | 0001564590-20-004041 | Feb 10, 2020 | Dec 31, 2019 |
| 10-Q | Q3 2019 10-Q | 0001564590-19-031249 | Aug 9, 2019 | Jun 30, 2019 |
| 10-Q | Q2 2019 10-Q - MARCH 31, 2019 | 0001564590-19-018517 | May 10, 2019 | Mar 31, 2019 |
| 10-Q | 10-Q | 0001564590-19-002428 | Feb 8, 2019 | Dec 31, 2018 |
| 10-Q | 10-Q | 0001564590-18-021062 | Aug 9, 2018 | Jun 30, 2018 |
| 10-Q | Q2 2018 10-Q | 0001564590-18-012940 | May 10, 2018 | Mar 31, 2018 |
| 10-Q | Q1'18 10-Q | 0001564590-18-001764 | Feb 9, 2018 | Dec 31, 2017 |
| 10-Q | Q3 2017 10-Q | 0001564590-17-016945 | Aug 9, 2017 | Jun 30, 2017 |
| 10-Q | 10-Q | 0001564590-17-010224 | May 10, 2017 | Mar 31, 2017 |
| 10-Q | 10-Q | 0001564590-17-001298 | Feb 9, 2017 | Dec 31, 2016 |
| 10-Q | FORM 10-Q | 0001193125-16-676744 | Aug 9, 2016 | Jun 30, 2016 |
| 10-Q | 10-Q | 0001193125-16-585576 | May 10, 2016 | Mar 31, 2016 |
| 10-Q | FORM 10-Q | 0001193125-16-455395 | Feb 9, 2016 | Dec 31, 2015 |
| 10-Q | FORM 10-Q | 0001193125-15-284854 | Aug 10, 2015 | Jun 30, 2015 |
| 10-Q | FORM 10-Q | 0001193125-15-179595 | May 8, 2015 | Mar 31, 2015 |
| 10-Q | FORM 10-Q | 0001193125-15-037392 | Feb 6, 2015 | Dec 31, 2014 |
| 10-Q | FORM 10-Q | 0001193125-14-305189 | Aug 12, 2014 | Jun 30, 2014 |
| 10-Q | 10-Q | 0001193125-14-195008 | May 12, 2014 | Mar 31, 2014 |
| 10-Q | FORM 10-Q | 0001193125-14-051254 | Feb 13, 2014 | Dec 31, 2013 |
| 10-Q | FORM 10-Q | 0001193125-13-331068 | Aug 12, 2013 | Jun 30, 2013 |
| 10-Q | FORM 10-Q | 0001193125-13-220330 | May 15, 2013 | Mar 31, 2013 |